What is DIPG?

Diffuse Intrinsic Pontine Glioma (DIPG) is a high-grade cancer that grows like a spider-web in a part of the brain stem, called the pons.

As the tumour grows it puts pressure on the surrounding nerves that control essential functions such as swallowing, eye movement, eyesight, and balance.

DIPG most commonly affects children between the ages of 4 and 11 and accounts for roughly 10-15% of all paediatric brain tumours.

While the ability to think, understand, recognise, feel and remember are all preserved; as the tumour progresses it interferes with breathing and heartbeat, which ultimately results in death.

DIPG in a nutshell

 
 

DIPG Collective +
Matt Dun

The DIPG / DMG Collaborative is a collection of foundations with the common interest of inspiring and funding research to cure DIPG / DMG. The Collective believes that through finding a cure, significant advances in other cancer research will be made. They refer to this as a ‘home run strategy’.

Made up of over 20 foundations, they cooperatively fund between $1,000,000 to $2,000,000 in DIPG / DMG research every two years. Their goal is to find the balance of research transparency, institutional collaboration and the elimination of duplication. The funds support both clinical and translational research worldwide.

In this video, Dr Matt Dun speaks about his research of DIPG, the challenges in the complexity of this cancer, and the design of future treatment plans.

While this interview contains a level of scientific understanding that’s well over my head, it paints a relevant picture of what DIPG is, why it’s so deadly and complex to cure. And gives me hope that there’s incredibly smart scientists dedicating their waking hours (and likely their sleep states too) to finding the cure to this disease.

 
 

Paediatric Palliative Care

When a family is told to ‘go home and make memories’ time becomes so very precious. I feel like I lived a lifetime with Jem in her 8 month illness. We were forced to be so present, not wanting to waste a moment of it; the luxury of tomorrow’s uncertain.

It occurs to me that even 100 years wouldn’t have been enough and I was so blessed to have 15 of the best with her.

I can’t sugar coat it though, that’s just time and counselling talking*; those months were also harrowing.

Pediatric terminal illness is exactly the shit show you might imagine it to be — and then some. I wager every family who's walked this lonely path has a pocket full of shocking and usually unrepeatable experiences; not all from the devastation of a horrid disease, but from the circumstances families are forced to navigate to have their kids cared for.

The bottom line is that some children will, and most children will not — receive specialist palliative and end-of-life care when dying from a serious illness.

Only some children will be psychologically supported at an age appropriate level.

Only some families given the tools to talk about their child’s imminent death. Perhaps you can imagine it for a moment, having that conversation with your kid? With their siblings?

Only some children will be given a personalised pain management plan. The age appropriate medicines that deliver comfort and dignity. The medicine that might also give their grieving family some assurance, that they didn’t die in pain.

Compassionate care is a basic human right; it’s the type of treatment we might feel entitled to receive as adults, at our time. And we probably will, because our care is funded.

Specialist paediatric palliative care is only funded to be available in Auckland. And with a dollar amount that doesn’t include all children; not even all those dying from serious illness in Auckland. It’s the post code lottery, with a bonus-ball of age discrimination.

I am grateful that Jemima received palliative care from the only Paediatric Specialist doctor working outside of Auckland. Dr Amanda Evans, founder of Rei Kotuku.

Rei Kotuku is a registered charity that provides specialist palliative care to children and their families without charge, through the generosity of a single anonymous donor.